Short-Course RT Plus Chemo Can Decrease Distant Metastasis in High-Risk LARC
Compared with standard care, preoperative short-course RT followed by chemotherapy can decrease distant metastasis in patients with high-risk LARC.
Compared with standard care, preoperative short-course RT followed by chemotherapy can decrease distant metastasis in patients with high-risk LARC.
At three, six, and nine years, overall survival was 64, 43, and 26 percent and progression-free survival was 88, 78, and 78 percent, respectively.
A retrospective study analyzed toxicity rates and reports on cosmetic outcomes from patients who underwent adjuvant proton-based radiotherapy after breast-conserving surgery.
A second course of stereotactic body radiation therapy (SBRT) is an important therapeutic strategy to consider for men with recurrent oligometastatic prostate cancer after an initial course of SBRT, according to investigators.
A review of the relationship between cancer, pain, pain management, and radiotherapy.
A study of the literature explored the potential of carotid IMT to predict risk of coronary artery disease in patients undergoing radiotherapy for HNC.
Investigators reported findings from the first randomized trial to evaluate the use of metastasis-directed therapy with hormone therapy in patients with oligometastatic prostate cancer.
Investigators characterized the toxicity of stereotactic body radiotherapy for oligometastases from predominantly prostate, colorectal, breast, and lung cancer.
Researchers sought to determine the relationship between direct radiation dose and inflammation and regional hepatic function after stereotactic body radiation therapy for hepatocellular carcinoma.
Researchers sought to determine the risk factors for radiotherapy-associated sarcomas in women with breast cancer.